Some genomic researchers and test developers say that the field is inexorably moving toward the whole-genome sequencing of healthy people, writes Muin Khoury, the director of the Office of Public Health Genomics at the US Centers for Disease Control and Prevention. He adds, though, that whole-genome sequencing should be subject to the same study as other screening tools before it is widely adopted.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Off and Running

Gauge of Risk

This Week in PNAS

This Week in Science

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.